Search all

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Australia

Austria

Belgium

Brazil *

Canada

China *

Denmark

Finland

France

Germany

Hong Kong *

India *

Ireland

Italy

Japan *

Luxembourg

Mexico *

Netherlands

Norway

Philippines *

Republic of Korea *

Singapore *

Spain

Sweden

Switzerland

Thailand *

United Kingdom

United States

cAMPZen Frozen Human Cannabinoid CB₁ Cell Line, CHO-K1 Cells

Our frozen, irradiated cAMPZen cells express a variety of GPCRs for binding and functional assays. No cell culture is required prior to testing.

View product information

Feature	Specification
Application	cAMP Drug Discovery & Development
G-Alpha Natural Receptor	G_i/G_o
Validation	cAMP

Request more information

Our frozen, irradiated cAMPZen cells express a variety of GPCRs for binding and functional assays. No cell culture is required prior to testing.

View product information

Product variant

Part #:

ES-110-CF

List price

USD 889.91

Your online price:

For research use only. Not for use in diagnostic procedures. This product contains living cells.

Total list price:

USD 889.91

Product information

Overview

Frozen Cells validated for cAMP testing: Cannabinoid CB1 receptor, human recombinant, in CHO-K1 host cell. We provide one vial of frozen cells (2.5 million cells/vial). Some of our Frozen cells may be restricted for sale in specified countries. Please inquire at your local sales office for more information. You are authorized to utilize these frozen cell preparations one time only. Any attempt to transfer, re-use, or propagate these cells is expressly unauthorized and a violation of the product terms and conditions of sale.

Specifications

Other specifications

Application	cAMP Drug Discovery & Development
Brand	cAMPZen
G-Alpha Natural Receptor	G_i/G_o
Host Cell Line	CHO-K1
Host Species	Human
One Unit Contains	1 vial(s)
Product Group	Cell Line
Receptor	Cannabinoid
Second Messenger Release	cAMP GTP exchange
Shipping Conditions	Shipped in Dry Ice
Target Class	GPCR
Therapeutic Area	Angiogenesis Cardiovascular Central Nervous System Gastrointestinal Inflammation Metabolic Pain
Unit Size	2.5 million cells
Validation	cAMP